HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazumi Tsubakio-Yamamoto Selected Research

Hypertriglyceridemia

9/2010Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.
6/2010Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
5/2009Chylomicron remnants are increased in the postprandial state in CD36 deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazumi Tsubakio-Yamamoto Research Topics

Disease

8Atherosclerosis
10/2013 - 07/2007
7Hyperlipidemias (Hyperlipidemia)
09/2012 - 04/2008
5Coronary Artery Disease (Coronary Atherosclerosis)
09/2012 - 06/2007
5Cardiovascular Diseases (Cardiovascular Disease)
01/2012 - 10/2007
3Platelet Glycoprotein IV Deficiency
01/2012 - 05/2009
3Coronary Disease (Coronary Heart Disease)
09/2011 - 12/2009
3Hypertriglyceridemia
09/2010 - 05/2009
2Inflammation (Inflammations)
10/2013 - 01/2012
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2012 - 09/2010
2Tangier Disease
06/2009 - 06/2007
1Insulin Resistance
12/2012
1Coronary Stenosis (Coronary Artery Stenosis)
09/2012
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2012
1Sitosterolemia
09/2010
1Hypercholesterolemia
09/2010
1Obesity
09/2010
1Xanthomatosis (Xanthoma)
09/2010
1Hyperlipoproteinemia Type III (Broad Beta Disease)
12/2009
1Hyperglycemia
05/2009
1Dyslipidemias (Dyslipidemia)
05/2009
1Hypertension (High Blood Pressure)
05/2009
1Hypoadiponectinemia
10/2007
1Atherosclerotic Plaque (Atheroma)
07/2007

Drug/Important Bio-Agent (IBA)

6CholesterolIBA
12/2012 - 07/2007
6HDL LipoproteinsIBA
01/2012 - 06/2007
5oxidized low density lipoproteinIBA
12/2012 - 12/2009
5Lipoproteins (Lipoprotein)IBA
12/2012 - 05/2009
5Apolipoprotein B-48IBA
09/2012 - 01/2011
4Triglycerides (Triacylglycerol)IBA
01/2012 - 05/2009
4HDL CholesterolIBA
06/2010 - 07/2007
3AdiponectinIBA
12/2012 - 07/2007
3Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2008 - 07/2007
2Proteins (Proteins, Gene)FDA Link
10/2013 - 05/2010
2Chylomicron RemnantsIBA
09/2012 - 05/2009
2ChylomicronsIBA
09/2012 - 09/2011
2LDL CholesterolIBA
09/2010 - 05/2010
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
09/2010 - 06/2009
2Ezetimibe (Zetia)FDA Link
09/2010 - 09/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2010 - 05/2010
1Apolipoproteins E (ApoE)IBA
10/2013
1ProgranulinsIBA
10/2013
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1ApolipoproteinsIBA
09/2012
1Biomarkers (Surrogate Marker)IBA
09/2012
1Hypolipidemic Agents (Antihyperlipidemics)IBA
01/2012
1CD36 AntigensIBA
01/2012
1Probucol (Lorelco)FDA Link
01/2012
1AntioxidantsIBA
01/2012
1campesterolIBA
09/2010
1gamma-sitosterol (beta-sitosterol)IBA
09/2010
1Adenosine Triphosphate (ATP)IBA
09/2010
1Bile Acids and Salts (Bile Acids)IBA
09/2010
1LDL Lipoproteins (beta Lipoproteins)IBA
09/2010
1Phytosterols (Plant Sterols)IBA
09/2010
1SterolsIBA
09/2010
1Fenofibrate (CiL)FDA LinkGeneric
06/2010
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
05/2010
1EnzymesIBA
05/2010
1polyacrylamideIBA
12/2009
1Cholesterol Esters (Cholesteryl Esters)IBA
06/2009
1PPAR gammaIBA
10/2008
1IDL Lipoproteins (Lipoprotein, IDL)IBA
04/2008

Therapy/Procedure

1Percutaneous Coronary Intervention
09/2010
1Blood Component Removal (Apheresis)
09/2010
1Drug Therapy (Chemotherapy)
09/2010
1Therapeutics
09/2010